Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Zoledronate, Dexamethasone, and Low-Dose Thalidomide: A Phase II Trial.

Autor: Klueppelberg, Uwe *, Smith, Eric L.P. *, Braunstein, Marc J. *, Kahn, David *, Batuman, Olcay A.
Zdroj: In Blood 16 November 2006 108(11):5124-5124
Databáze: ScienceDirect